Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience
- 1 November 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 57 (4) , 944-952
- https://doi.org/10.1016/s0360-3016(03)00739-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Palladium-103 brachytherapy for prostate carcinomaPublished by Elsevier ,2000
- Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implantsMedical Physics, 1998
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- A Dose–Response Study for I-125 Prostate ImplantsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapySeminars in Surgical Oncology, 1997
- Interstitial implantation techniques in prostate cancerJournal of Surgical Oncology, 1997
- Interstitial Irradiation in Prostatic Cancer: Report of 10-Year ResultsPublished by Springer Nature ,1991